Can Use of Intravenous Methylene Blue Improve the Hemodynamics and Outcome of the Patients with Refractory Septic Shock? An Observational Study

INTRODUCTION: Refractory shock, which fails to respond to conventional vasopressor therapy, is a common complication of sepsis. Methylene blue has emerged as a potential adjunctive treatment option for reversing refractory shock in sepsis. The aim of this study was to evaluate the impact of intraven...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajbanshi, Lalit Kumar, Bajracharya, Akriti, Arjyal, Batsalya, Devkota, Dikshya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504645/
https://www.ncbi.nlm.nih.gov/pubmed/37719353
http://dx.doi.org/10.5005/jp-journals-10071-24535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504645/
https://www.ncbi.nlm.nih.gov/pubmed/37719353
http://dx.doi.org/10.5005/jp-journals-10071-24535

Ejemplares similares